-18.2%
MELI vs THC
+40.9%
-59.0%
-38.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.6% | +0.6% | -1.2% | -0.7% |
| 7D | +0.6% | -0.7% | +1.3% | +0.7% |
| 30D | +2.9% | +1.3% | +1.6% | +2.6% |
| 3M | +21.0% | +64.2% | -43.2% | +10.0% |
| 6M | +11.8% | +8.3% | +3.6% | +9.5% |
| YTD | -1.8% | +33.4% | -35.2% | -7.8% |
| 1Y | -18.2% | +37.7% | -55.8% | -24.0% |
| All | -18.2% | +40.9% | -59.0% | -24.0% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling